Negative rating slashes 10% from Intuitive Surgical | Wall Street Beat

MassDevice.com Wall Street Beat

A research report blasting Intuitive Surgical (NSDQ:ISRG) spooked investors on Wall Street yesterday and today, prompting a selloff that’s shaved some 11% from the medical device company’s share price.

Citron Research, citing several factors that investors had ignored, said yesterday that it expects ISRG shares to drop to $350 over the next year and as low as $250 over the next 18 months.

ISRG shares began yesterday at $547.33 each, but as The Street digested the Citron report unusually heavy trading plunged the stock to a $515.45 close, down 5.7% on the day. Shares opened today at $508.82 and slipped another 5.3% to close at $488.31 apiece.

Sign up to get our free newsletters delivered straight to your inbox

The Citron researchers said the stock’s high earnings multiple belies "a track record of excessive and unjustified marketing claims, the utter lack of clinical evidence of superior medical outcomes when using its product for surgery, and the gathering storm of legal liability accruing to the company due to its failure to adequately disclose risks prior to its technology causing adverse surgical outcomes, scattered among the hundreds of thousands of surgeries performed with its robotic surgery devices," according to their report (PDF).

"Intuitive Surgical (ISRG) is unique because the da Vinci is a product that has not been sold to meet patient need, as most medical devices are, but rather it has been sold using fear to hospital management purchasing committees. Aggressive salespeople have escalated a ‘medical arms race’ into high technology, regardless of whether surgeries with this device produce significant medical benefit or not," the researchers wrote, citing key developments over the past 4 weeks:

  • “Three new, highly credible lawsuits over hysterectomies with bad outcomes have been filed – in addition to 6 really ominous ones from earlier in the year.”
  • "Large insider sales. Within the last month, chairman Lonnie Smith sold shares from options exercise (not 10(5)b) netting over $50 million, a rather large percentage of his recently apportioned stake."
  • “Peer criticism – a number of recent articles summarizing from highly credible, recent studies that highlight the gap between the company marketing materials’ claims and full scientific disclosure of the true risks and differentials in medical outcomes. This gap creates the basis for legal challenges to the company due to inadequate disclosure of the risks of bad outcomes.”
  • "Further skepticism about the true cost/benefit of robotic surgeries."
  • "Indications of loss of morale and sharp erosion of confidence in management and oversaturation coming through the sales force."

And that’s not all, at least according to Citron, citing a "severe vacuum of real scientific evidence" backing use of the da Vinci system.

"The most serious issue facing Intuitive is that, while its deployment is well past the 10-year point into mainstream healthcare in the U.S., there is still a severe vacuum of real scientific evidence that the da Vinci is of any clinical benefit, when the full arc of costs and outcomes are weighed, in the most commonly performed surgeries in which it is utilized. While this is not a new thought, the current legal cases will bring this issue to the forefront," according to the researchers.

 Allergan closes Skinmedica buyout
Allergan (NYSE:AGN) said it’s closed its $350 million acquisition of SkinMedica’s topical aesthetics skin care business.
Read more

 Winner Medical goes private
Chinese medical dressings maker Winner Medical Group (NSDQ:WWIN) closed its "going private transaction" Dec. 11, paying $4.50 per share to its former stockholders.
Read more

 Lombard Medical extends funding round
Lombard Medical Technologies (LON:LMT) said it’s extending its funding round by 6 months, until June 30, 2013, for the 2nd tranche worth a hoped-for £14.1 million (about $23.0 million). MVM Life Science Partners is backing out of the deal, replaced by LSP Life Sciences Fund.
Read more

 PatientSafe, Lumo Body Tech, Ortho Kinematics drum up investors

mHealth company PatientSafe Solutions drummed up $13.3 million of a hoped-for $25.7 million; Lumo Body Tech raised $5 million for its Lumoback posture sensor; and spine imaging informatics firm Ortho Kinematics pulled in more than $2 million in a Series B round.

Read some more

 Analysts’ ups and downs

  • Abbott (NYSE:ABT): William Blair & Co. initiates coverage with "outperform" rating.
  • Conceptus (NSDQ:CPTS): Stifel Nicolaus initiates coverage with "buy" rating, $26 price target.
  • Cytomedix (OTC:CMXI): LifeSci Advisors initiates coverage.
  • Henry Schein (NSDQ:HSIC): Stifel Nicolaus initiates coverage with "hold" rating.
  • Stryker (NYSE:SYK): Standpoint Research cuts to "hold" from "buy" rating.

RSS From Medical Design & Outsourcing

  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]
  • Continuous 225W with natural convection for medical type BF power supply
    Powerbox, a European power supply company, introduces new Medline 225 series ac and dc single output open frame converters for medical type BF applications. The new OFM225 with its 3 x 5 in. footprint and 1.5 in. height is designed for a continuous output power of 225W with natural convection and 40°C ambient temperature, increasing to […]
  • Using data science to achieve ultra-low dose CT image reconstruction
    Prof. Jeff Fessler and Prof. Yong Long, Ph.D. of the University of Michigan-Shanghai Jiao Tong University (UM-SJTU) Joint Institute are collaborating on a project to develop a dramatically improved approach to low-dose X-ray CT image formation by extracting and using information from a big-data corpus of regular dose X-Ray Computed Tomography (CT) images. The research is […]

Leave a Reply